Beclomethasone Dipropionate Patent Expiration
Beclomethasone Dipropionate was first introduced by Schering Corp Sub Schering Plough Corp
Beclomethasone Dipropionate Patents
Given below is the list of patents protecting Beclomethasone Dipropionate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Qvar Redihaler | US11583643 | Inhalers and related methods | Aug 19, 2041 | Norton Waterford |
| Qvar Redihaler | US11957832 | Breath actuated inhaler | May 05, 2041 | Norton Waterford |
| Qvar Redihaler | US11559637 | Inhalers and related methods | Jul 21, 2039 | Norton Waterford |
| Qvar Redihaler | US10792447 | Breath actuated inhaler | Jan 25, 2039 | Norton Waterford |
| Qvar Redihaler | US11395888 | Inhalers and related methods | Jan 26, 2038 | Norton Waterford |
| Qvar Redihaler | US11793953 | Inhalers and related methods | Jan 26, 2038 | Norton Waterford |
| Qvar Redihaler | US11865247 | Inhalers and related methods | Jan 26, 2038 | Norton Waterford |
| Qvar Redihaler | US11896759 | Inhalers and related methods | Jan 26, 2038 | Norton Waterford |
| Qvar 40 | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Qvar 80 | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Qvar Redihaler | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Norton Waterford |
| Qnasl | US10188811 | Nasal spray device | Oct 21, 2031 | Teva Branded Pharm |
| Qvar Redihaler | US8931476 | Inhaler | Jul 17, 2031 | Norton Waterford |
| Qvar 40 | US10022509 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Qvar 40 | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Qvar 40 | US10086156 | Dose counter for inhaler and method for counting doses | May 18, 2031 | Teva Branded Pharm |
| Qvar 40 | US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Qvar 40 | US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Qvar 40 | US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Qvar 40 | US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Qvar 80 | US10022509 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Qvar 80 | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Qvar 80 | US10086156 | Dose counter for inhaler and method for counting doses | May 18, 2031 | Teva Branded Pharm |
| Qvar 80 | US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Qvar 80 | US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Qvar 80 | US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Qvar 80 | US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Qvar Redihaler | US10022509 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Norton Waterford |
| Qvar Redihaler | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Norton Waterford |
| Qvar Redihaler | US10086156 | Dose counter for inhaler and method for counting doses | May 18, 2031 | Norton Waterford |
| Qvar Redihaler | US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Norton Waterford |
| Qvar Redihaler | US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Norton Waterford |
| Qvar Redihaler | US8132712 | Metered-dose inhaler | Sep 07, 2028 | Norton Waterford |
| Qnasl | US7780038 | Dispensing apparatus with dosage counter | Jan 24, 2027 | Teva Branded Pharm |
| Qvar Redihaler | US7637260 | Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber |
Aug 25, 2020
(Expired) | Norton Waterford |
| Qvar 40 | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Teva Branded Pharm |
| Qvar 80 | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Teva Branded Pharm |
| Qvar Redihaler | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Norton Waterford |
| Qnasl | US5776432 | Beclomethasone solution aerosol formulations |
Jul 07, 2015
(Expired) | Teva Branded Pharm |
| Qvar 40 | US5776432 | Beclomethasone solution aerosol formulations |
Jul 07, 2015
(Expired) | Teva Branded Pharm |
| Qvar 80 | US5776432 | Beclomethasone solution aerosol formulations |
Jul 07, 2015
(Expired) | Teva Branded Pharm |
| Qnasl | US5683677 | Medicinal aerosol formulations |
Nov 04, 2014
(Expired) | Teva Branded Pharm |
| Qvar 40 | US5683677 | Medicinal aerosol formulations |
Nov 04, 2014
(Expired) | Teva Branded Pharm |
| Qvar 80 | US5683677 | Medicinal aerosol formulations |
Nov 04, 2014
(Expired) | Teva Branded Pharm |
| Qnasl | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Teva Branded Pharm |
| Qvar 40 | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Teva Branded Pharm |
| Qvar 80 | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Teva Branded Pharm |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Beclomethasone Dipropionate's patents.
Latest Legal Activities on Beclomethasone Dipropionate's Patents
Given below is the list recent legal activities going on the following patents of Beclomethasone Dipropionate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Mar, 2024 | US10792447 |
| Recordation of Patent Grant Mailed Critical | 13 Feb, 2024 | US11896759 |
| Recordation of Patent eGrant | 13 Feb, 2024 | US11896759 |
| Email Notification Critical | 13 Feb, 2024 | US11896759 |
| Patent Issue Date Used in PTA Calculation Critical | 13 Feb, 2024 | US11896759 |
| Patent eGrant Notification | 13 Feb, 2024 | US11896759 |
| Mail Patent eGrant Notification | 13 Feb, 2024 | US11896759 |
| Email Notification Critical | 25 Jan, 2024 | US11896759 |
| Issue Notification Mailed Critical | 24 Jan, 2024 | US11896759 |
| Dispatch to FDC | 16 Jan, 2024 | US11896759 |
Beclomethasone Dipropionate's Family Patents
